The "ImmunoDerm Dialogues" podcast, funded by Novartis Pharma AG, offers insights into immune-mediated dermatological diseases and their connection to systemic immunity.
Experts discuss how T-helper cell dysregulation impacts conditions like lupus, hidradenitis suppurativa (HS), and atopic dermatitis. The conversation also highlights BTK inhibition as a novel therapeutic strategy, drawing from recent research.
This scientific content is intended for healthcare professionals' medical education.